Charles J. Lightdale, MD, explores the latest trends in EUS technology in the setting of GI oncology, as framed by data presented at ACG 2007. Medscape Gastroenterology
The combination of capecitabine, oxaliplatin, and irinotecan represents a feasible and active regimen for the first-line treatment of metastatic colorectal cancer. Annals of Oncology
The authors consider H. pylori resistance from a different perspective: discussing concepts of resistance that are part of mainstream thinking for other infectious diseases, but not for H. pylori. Nature Clinical Practice Gastroenterology & Hepatology
Liver resection does not benefit patients with colorectal liver metastases if their celiac or para-aortic regional lymph nodes are involved, even if the disease responds to preoperative chemotherapy. Reuters Health Information
Emmet Keeffe, MD, MACP, reviews the indications for treatment and duration of therapy in hepatitis B, as based on current best evidence. Medscape Gastroenterology
